Comparison Between On‐Demand Dosing of Dapoxetine Alone and Dapoxetine Plus Mirodenafil in Patients with Lifelong Premature Ejaculation: Prospective, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Study

Won Ki Lee; Seong Ho Lee; Sung Tae Cho; Yong Sung Lee; Cheol Young Oh; Changhee Yoo; Jin Seon Cho; Sang Kon Lee; Dae Yul Yang

doi:10.1111/jsm.12287

Comparison Between On‐Demand Dosing of Dapoxetine Alone and Dapoxetine Plus Mirodenafil in Patients with Lifelong Premature Ejaculation: Prospective, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Study

Journal of Sexual Medicine ◽

10.1111/jsm.12287 ◽

2013 ◽

Vol 10 (11) ◽

pp. 2832-2841 ◽

Cited By ~ 21

Author(s):

Won Ki Lee ◽

Seong Ho Lee ◽

Sung Tae Cho ◽

Yong Sung Lee ◽

Cheol Young Oh ◽

...

Keyword(s):

Multicenter Study ◽

Premature Ejaculation ◽

Double Blind ◽

Double Blind Placebo ◽

On Demand ◽

Lifelong Premature Ejaculation

Download Full-text

The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX)

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2019.05.015 ◽

2019 ◽

Vol 16 (8) ◽

pp. 1188-1198 ◽

Cited By ~ 2

Author(s):

Stanley Althof ◽

Ian H. Osterloh ◽

Gary J. Muirhead ◽

Katie George ◽

Nicolas Girard ◽

...

Keyword(s):

Premature Ejaculation ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculatory Latency ◽

Oxytocin Antagonist ◽

Lifelong Premature Ejaculation

Download Full-text

213 Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation; multicenter, prospective, randomized, double-blind, and placebo-controlled

European Urology Supplements ◽

10.1016/s1569-9056(13)60700-9 ◽

2013 ◽

Vol 12 (1) ◽

pp. e213-e214

Author(s):

C. Yoo ◽

W.Y. Cho ◽

J.S. Cho ◽

W.K. Lee ◽

S.K. Lee ◽

...

Keyword(s):

Premature Ejaculation ◽

Double Blind ◽

On Demand ◽

Lifelong Premature Ejaculation

Download Full-text

Reply to Christopher C.K. Ho's Letter to the Editor re: David Bar-Or, Kristin M. Salottolo, Alessandro Orlando, James V. Winkler. A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes. Eur Urol 2012;61:736–43

European Urology ◽

10.1016/j.eururo.2011.10.008 ◽

2012 ◽

Vol 61 (4) ◽

pp. e25-e26

Author(s):

David Bar-Or ◽

Kristin M. Salottolo

Keyword(s):

Multicenter Study ◽

Premature Ejaculation ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Letter To The Editor

Download Full-text

Re: David Bar-Or, Kristin M. Salottolo, Alessandro Orlando, James V. Winkler. A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes. Eur Urol 2012;61:736–43

European Urology ◽

10.1016/j.eururo.2011.09.007 ◽

2012 ◽

Vol 61 (4) ◽

pp. e23-e24 ◽

Cited By ~ 1

Author(s):

Christopher C.K. Ho

Keyword(s):

Multicenter Study ◽

Premature Ejaculation ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet

Download Full-text

A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes

European Urology ◽

10.1016/j.eururo.2011.08.039 ◽

2012 ◽

Vol 61 (4) ◽

pp. 736-743 ◽

Cited By ~ 62

Author(s):

David Bar-Or ◽

Kristin M. Salottolo ◽

Alessandro Orlando ◽

James V. Winkler

Keyword(s):

Multicenter Study ◽

Premature Ejaculation ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet

Download Full-text

The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX)

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2019.05.016 ◽

2019 ◽

Vol 16 (8) ◽

pp. 1178-1187 ◽

Cited By ~ 2

Author(s):

Christopher McMahon ◽

Stanley Althof ◽

Raymond Rosen ◽

Francois Giuliano ◽

Martin Miner ◽

...

Keyword(s):

Patient Reported Outcomes ◽

Premature Ejaculation ◽

Proof Of Concept ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculatory Latency ◽

Patient Reported ◽

Oxytocin Antagonist ◽

Lifelong Premature Ejaculation

Download Full-text

A Double Blind, Placebo Controlled, Randomized Trial to Evaluate the Efficacy and Tolerability of On-Demand Oral Pregablin (150 mg and 75 mg) in Treatment of Premature Ejaculation

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2019.12.014 ◽

2020 ◽

Vol 17 (3) ◽

pp. 442-446

Author(s):

Mohamed Refaat El Najjar ◽

Mohamed El Hariri ◽

Ali Ramadan ◽

Abd-Alrahman Hefny Hashem

Keyword(s):

Randomized Trial ◽

Premature Ejaculation ◽

Double Blind ◽

Double Blind Placebo ◽

On Demand

Download Full-text

A randomized, double-blind, placebo-controlled, crossover trial of "on-demand" tramadol for treatment of premature ejaculation

Urology Annals ◽

10.4103/0974-7796.150481 ◽

2015 ◽

Vol 7 (2) ◽

pp. 205 ◽

Cited By ~ 7

Author(s):

AhmadA Elderwy ◽

Sherief Abulsorour ◽

SaraM Awad ◽

AhmedS Safwat ◽

Ahmed Altaher ◽

...

Keyword(s):

Premature Ejaculation ◽

Crossover Trial ◽

Double Blind ◽

Double Blind Placebo ◽

On Demand

Download Full-text

A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes

Yearbook of Urology ◽

10.1016/j.yuro.2012.05.065 ◽

2012 ◽

Vol 2012 ◽

pp. 138-139

Author(s):

A.W. Shindel

Keyword(s):

Multicenter Study ◽

Premature Ejaculation ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet

Download Full-text

Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study

Annals of Oncology ◽

10.1093/annonc/mdl081 ◽

2006 ◽

Vol 17 (7) ◽

pp. 1096-1102 ◽

Cited By ~ 52

Author(s):

D.A. Richards ◽

K.A. Boehm ◽

D.M. Waterhouse ◽

D.J. Wagener ◽

S.S. Krishnamurthi ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Multicenter Study ◽

Advanced Pancreatic Cancer ◽

Double Blind ◽

Double Blind Placebo

Download Full-text